These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 19425476)

  • 1. [Neuroprotection in glaucoma].
    Kuprjanowicz L; Karczewicz D
    Ann Acad Med Stetin; 2007; 53 Suppl 1():22-9. PubMed ID: 19425476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neuroprotection and vasoprotection in glaucoma].
    Ignat F
    Oftalmologia; 2004; 48(2):5-14. PubMed ID: 15341092
    [No Abstract]   [Full Text] [Related]  

  • 3. History of neuroprotection and rationale as a therapy for glaucoma.
    Levin LA; Peeples P
    Am J Manag Care; 2008 Feb; 14(1 Suppl):S11-4. PubMed ID: 18284310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prospects for neuroprotective glaucoma therapy].
    Grehn F
    Ophthalmologe; 2001 Oct; 98(10):925-8. PubMed ID: 11699312
    [No Abstract]   [Full Text] [Related]  

  • 5. Neuroprotection: extrapolating from neurologic diseases to the eye.
    Danesh-Meyer HV; Levin LA
    Am J Ophthalmol; 2009 Aug; 148(2):186-191.e2. PubMed ID: 19464671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Glaucoma neuroprotection--how far is it from a dream to reality].
    Ge J
    Zhonghua Yan Ke Za Zhi; 2008 May; 44(5):385-7. PubMed ID: 18953889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trials in neuroprotection.
    Whitcup SM
    Prog Brain Res; 2008; 173():323-35. PubMed ID: 18929119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Modern anti-glaucoma drugs and their secondary effects].
    Mermoud A
    Rev Med Suisse Romande; 1998 Nov; 118(11):937-40. PubMed ID: 9865122
    [No Abstract]   [Full Text] [Related]  

  • 9. Recent clinical findings with memantine should not mean that the idea of neuroprotection in glaucoma is abandoned.
    Osborne NN
    Acta Ophthalmol; 2009 Jun; 87(4):450-4. PubMed ID: 19141144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neuroprotection. Bases and possibilities of a future clinical use].
    Lagrèze WA
    Ophthalmologe; 2001 Mar; 98(3):235-6. PubMed ID: 11320808
    [No Abstract]   [Full Text] [Related]  

  • 11. Heads up for glaucoma research and clinical practice.
    Adams AJ
    Optom Vis Sci; 2008 May; 85(5):287. PubMed ID: 18451732
    [No Abstract]   [Full Text] [Related]  

  • 12. Erythropoietin: a candidate neuroprotective agent in the treatment of glaucoma.
    Tsai JC; Song BJ; Wu L; Forbes M
    J Glaucoma; 2007 Sep; 16(6):567-71. PubMed ID: 17873720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential roles of (endo)cannabinoids in the treatment of glaucoma: from intraocular pressure control to neuroprotection.
    Nucci C; Bari M; Spanò A; Corasaniti M; Bagetta G; Maccarrone M; Morrone LA
    Prog Brain Res; 2008; 173():451-64. PubMed ID: 18929127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges in the development of glaucoma neuroprotection therapy.
    Liu Y; Pang IH
    Cell Tissue Res; 2013 Aug; 353(2):253-60. PubMed ID: 23474740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neuroprotection in Parkinson's disease: analysis though group of experts' methodology].
    Linazasoro G; Sesar A; Valldeoriola F; Compta Y; Herrero MT; Martínez Castrillo JC; López Lozano JJ; Bergaretxe A; Vela L; Fernández JM; Castro A; Kulisevski J; Lezcano E; Vaamonde J; López Del Val J; Chacón J; Vivancos F; Luquin R; Aguilar M; Burguera JA; Salvador C; Menéndez Guisasola L; Catalán MJ; Mir P; Campos V; Grandas F; Mínguez A; Balaguer E; Yáñez R; Leiva C; García Ruiz P; Cubo E
    Neurologia; 2009 Mar; 24(2):113-24. PubMed ID: 19322690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological neuroprotection for glaucoma.
    Holló G
    Drugs; 2007; 67(15):2291. PubMed ID: 17927292
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prospects in the medical treatment of glaucomatous neuropathy. Basics of neuroprotection].
    Detry-Morel M
    J Fr Ophtalmol; 1999 Feb; 22(1):122-34. PubMed ID: 10221206
    [No Abstract]   [Full Text] [Related]  

  • 18. Neuroprotection and other novel therapies for glaucoma.
    Nucci C; Strouthidis NG; Khaw PT
    Curr Opin Pharmacol; 2013 Feb; 13(1):1-4. PubMed ID: 23142029
    [No Abstract]   [Full Text] [Related]  

  • 19. Potential neuroprotective biomolecules in ophthalmology.
    Afarid M; Sanie-Jahromi F
    Int Ophthalmol; 2021 Mar; 41(3):1103-1109. PubMed ID: 33180279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasoprotection as neuroprotection for the optic nerve.
    Harris A; Ciulla TA; Kagemann L; Zarfati D; Martin B
    Eye (Lond); 2000 Jun; 14 ( Pt 3B)():473-5. PubMed ID: 11026976
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.